Introduction
Pacing is relatively uncommon in the neonatal period, with the 2 main indications being either acquired postoperative complete atrioventricular block (CAVB) or congenital antibody-mediated CAVB. 1 The detrimental effect of pacing resulting in dilated cardiomyopathy (DCM) has been increasingly recognized in infants with CAVB requiring pacemaker implantation. 2, 3 Minimizing the frequency of ventricular pacing and the use of cardiac resynchronization therapy (CRT) have been demonstrated to be effective interventions to invoke reverse remodeling in adults as well as infants with pacemaker-mediated DCM.
2,4-6 Despite a growing number of reports on infants with CAVB who progressed to develop pacemaker-mediated DCM, the mechanism for this pathology remains unclear and an evidence-based approach for management has yet to be described. Both electromechanical dyssynchrony due to single-site ventricular pacing and high ventricular paced rates have been proposed as potential mechanisms for these observations. 2, 7 Most of the reports to date include patients with antibody-mediated AV block, with few describing cases of acquired CAVB. It has been described that patients with antibody-mediated AV block have a degree of myofibrillar hypertrophy prior to pacemaker insertion that can progress to mitochondrial morphologic changes, degenerative fibrosis, and fatty deposition with long-term pacing. 8 Since this could be a confounder in the assessment of ventricular function and remodeling, investigating cases of acquired, as opposed to antibody-mediated, CAVB may be more helpful to understand the underlying pathophysiology of pacemaker-mediated cardiomyopathy. We report a case of DCM in a patient with acquired CAVB that supports the concept that pacing activation at high rates within a normal physiologic range is a significant contributor to the development of DCM in the immature myocardium.
Case report
A newborn male twin was born with an antenatal diagnosis of d-transposition of the great arteries with intact ventricular septum. Postnatally, the diagnosis was confirmed to be d-transposition of the great arteries with a small perimembranous ventricular septal defect (VSD). He initially underwent a balloon atrial septostomy followed by an arterial switch operation and VSD repair on day 5 of life. The VSD was repaired with a single pledgeted horizontal mattress suture and the cardiopulmonary bypass and cross-clamp times were 138 minutes and 75 minutes, respectively. The coronary arteries were identified intraoperatively to be in a usual orientation and the coronary transfer was uncomplicated. He weaned from cardiopulmonary bypass without inotropes in an
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Pacemaker-mediated dysfunction and dilation from high-rate ventricular pacing is reversible by reducing the upper-tracking rate in a dual-chamber pacing mode. KEYWORDS Cardiomyopathy; Complete atrioventricular heart block; Dualchamber pacemaker; Neonate; Pacemaker (Heart Rhythm Case Reports 2020;6:102-105) accelerated junctional rhythm, and was later found to have CAVB. On postoperative day 4, as per our institutional practice, a dual-chamber pacemaker implantation was performed owing to ongoing CAVB with a junctional escape of 65 beats per minute (bpm). Epicardial pacing leads were placed on the lateral surface of the right atrium and the anterior surface of the right ventricle near the right ventricular (RV) outflow tract. The device was initially set to a DDD mode with a lower rate of 100 bpm and upper tracking rate of 210 bpm and was A sensed and V paced the majority of the time. The lower rate was decreased to 80 bpm 2 weeks after implantation. At this time there was no evidence of ventricular dilation and the ventricular function was within normal limits based on an M-mode ejection fraction of 65%. After 2 months of follow-up, he remained clinically well but was found to have reduced left ventricular (LV) function with a biplane ejection fraction (BPEF) of 42% and ongoing septal dyskinesia (Figure 1 ). One year after pacemaker implantation, he remained clinically well despite a further reduction in ventricular function to a BPEF of 37%. His underlying rhythm remained in CAVB and the pacemaker was programmed to DDD mode with lower rate of 70 bpm and upper rate of 210 bpm. There were no alternative causes for ventricular dysfunction identified, with no events captured on device interrogation that were consistent with an atrial tachyarrhythmia and no residual structural lesions following the arterial switch operation and VSD repair. In particular, there were no symptoms or regional wall motion abnormalities to suggest compromised coronary perfusion. Owing to the ongoing ventricular dysfunction at this time, with a concern that highrate pacing may be contributing, he was started on atenolol. Over the following year, there was minimal improvement in cardiac function with beta-blocker therapy. Therefore, the upper tracking rate was reduced from 210 bpm to 160 bpm to reduce the average ventricular paced rate. The atrial and ventricular rate histograms from before and after the change in pacemaker settings are shown in Figure 2 . The atrial rate distribution appears unchanged between the 2 conditions whereas the ventricular rate distribution shifted to the left, indicating less frequent high-rate pacing when the upper rate was reduced from 210 bpm to 160 bpm. Over a 2-year period, his LV function normalized after a 33% improvement in BPEF (BPEF from 37% to 56%). Despite the improvement in function, the left ventricle remained dilated with an enddiastolic diameter of 4.5 cm (z-score 14.1). The atenolol was discontinued at this time, and his pacemaker settings were kept the same. Within 1 year, the LV function was preserved with a BPEF of 56% and the LV end-diastolic diameter had normalized with a diameter of 3.7 cm (z-score 10.4). Despite the significant changes in the patient's LV function and dimensions over time, he remained asymptomatic throughout this period of follow-up.
Discussion
We describe a patient with acquired CAVB in whom a rapid, but physiologic, pacing rate caused ventricular dysfunction. This was reversed by limiting the upper tracking rate, suggesting that pacemaker-mediated dysfunction in the immature myocardium is affected by heart rate. Tachycardia-induced cardiomyopathy is a well-known complication of incessant arrhythmia, but sinus nodederived rates do not cause this complication. However, the combination of sinus tachycardia and paced activation of the heart that is described by our case can lead to dysfunction and dilation. This is the first report describing improvement in pacemaker-induced DCM in a patient with congenital heart disease following reduction in the upper tracking rate while maintaining a dual-chamber pacing mode. Janou sek and colleagues 2 described a similar case where reverse remodeling of the left ventricle was observed following both the reduction in the paced rate and a change in the pacing mode from dual chamber to single chamber. This report removed both the mechanical dyssynchrony and high paced rates associated with RV pacing, implicating these changes as potential sources of ventricular dysfunction and dilation. Our case provides an example of reverse remodeling with a decrease in the pacing rate while preserving dual-chamber pacing with a single pacing site in the right ventricle. This suggests that ventricular function can be preserved while maintaining the hemodynamic benefit of AV synchrony in a dual-chamber pacing mode as long as a low upper rate is programmed.
Although a beta-blocker was prescribed at the onset of ventricular dysfunction, we attribute the LV remodeling to the change in pacemaker settings. The beta-blocker may have improved the ejection fraction but was unlikely to have contributed to remodeling. This is illustrated by the timeline for changes in ventricular dimensions with respect to the use of the beta-blocker. This shows that LV remodeling continued well after discontinuation of the medication and, instead, the change in ventricular dimensions correlates well with the adjustment to the pacemaker settings ( Figure 1) .
Unlike in other similar cases where remodeling was observed over a period of weeks following a change to CRT or VVI with a low back-up rate, 2 the duration for remodeling in our patient was prolonged over a period of 1 year. This may be attributed to the ongoing electromechanical dyssynchrony with single-site RV pacing, making this approach more appropriate for prevention of pacemakermediated LV dysfunction or an intervention for asymptomatic patients with evolving LV dysfunction or dilation. This approach was appropriate for our patient, since he was hemodynamically stable and asymptomatic at the time when LV dysfunction was first recognized.
Conclusion
The progression to DCM in patients that require ventricular pacing for CAVB is a well-described complication in infants and children. Understanding this process is especially important in consideration of pacing in neonates, since the incidence of pacemaker-mediated DCM is higher than in older children with a more mature myocardium. 3, 9 The mechanism for the development of DCM remains unclear but is believed to be related to 1 or a combination of electromechanical dyssynchrony from single-site RV pacing and high-rate ventricular pacing. CRT and low-rate single-chamber pacing have previously been shown to allow for reverse-remodeling of the left ventricle. We have described a unique case that shows paced activation at high physiologic rates can lead to DCM, and that this process can be reversed with lowrate dual-chamber pacing.
